Evidence map›Paper›PMID 29208908›Full record

ArticleScientific reports2017

Multiplex three-dimensional optical mapping of tumor immune microenvironment.

Steve Seung-Young Lee, Vytautas P Bindokas, Stephen J Kron

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Transmural Flow Upregulates PD-L1 Expression in Microvascular Networks.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Multiresolution 3D Optical Mapping of Immune Cell Infiltrates in Mouse Asthmatic Lung.American journal of respiratory cell and molecular biology · 2023
    Article
  13. Review
  14. Review
  15. Review
  16. FN3 linked nanobubbles as a targeted contrast agent for US imaging of cancer-associated human PD-L1.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Steve Seung-Young LeeDepartment of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL, USA.
Vytautas P BindokasIntegrated Light Microscopy Facility, The University of Chicago, Chicago, IL, USA.
Stephen J KronDepartment of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, IL, USA. skron@uchicago.edu.
University of Chicago · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
Radiation response within the tumor microenvironmentR01CA164492 · NCI · UNIVERSITY OF CHICAGO · PI KRON, STEPHEN J. · 2011 to 2015
$4.8M
Image-guided radiation-induced permeability (IGRIP) for IGDDR01CA199663 · NCI · UNIVERSITY OF CHICAGO · PI KRON, STEPHEN J., WEICHSELBAUM, RALPH R · 2015 to 2019
$2.5M
Environmentally-adaptive nanoparticles with focal irradiation for cancer therapyR01EB017791 · NIBIB · PURDUE UNIVERSITY · PI YEO, YOON · 2014 to 2018
$1.6M
Transparent Tumor Tomography (T3): Multi-Parameter 3D Imaging for Tumor ImmunotherapyK99EB022636 · NIBIB · UNIVERSITY OF CHICAGO · PI LEE, STEVE SEUNG-YOUNG · 2017 to 2018
$146k
NCI NIH HHS P30 CA014599NCI NIH HHS R01 CA164492NCI NIH HHS R01 CA199663NIBIB NIH HHS K99 EB022636NIBIB NIH HHS R01 EB017791
6 · The paper itself

Abstract

Recent developments in optical tissue clearing and microscopic imaging have advanced three-dimensional (3D) visualization of intact tissues and organs at high resolution. However, to expand applications to oncology, critical limitations of current methods must be addressed. Here we describe transparent tissue tomography (T3) as a tool for rapid, three-dimensional, multiplexed immunofluorescent tumor imaging. Cutting tumors into sub-millimeter macrosections enables simple and rapid immunofluorescence staining, optical clearing, and confocal microscope imaging. Registering and fusing macrosection images yields high resolution 3D maps of multiple tumor microenvironment components and biomarkers throughout a tumor. The 3D maps can be quantitatively evaluated by automated image analysis. As an application of T3, 3D mapping and analysis revealed a heterogeneous distribution of programmed death-ligand 1 (PD-L1) in Her2 transgenic mouse mammary tumors, with high expression limited to tumor cells at the periphery and to CD31

Indexed as

Tumor MicroenvironmentAnimalsB7-H1 AntigenErb-b2 Receptor Tyrosine KinasesFemaleHumansImaging, Three-DimensionalMaleMammary Neoplasms, AnimalMiceMice, Inbred BALB COptical ImagingTomography, X-Ray ComputedTumor Cells, CulturedB7-H1 AntigenCd274 protein, mouseErbb2 protein, mouseErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID29208908
PMCPMC5717053
OpenAlexW2768186151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.